These lncRNAs, already shown to be dysregulated in epithelial cancers, have not yet been investigated in these specific NSCLC cancer phenotypes or in the Rho signaling pathways; therefore, further investigation is required. This evidence concerns the gene RHO and non-small cell lung carcinoma.